Publication | Closed Access

Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study

Advanced Ovarian CancerMedicineMetronomic TherapyPharmacologyGynecologyLong-term Efficacy ResultsCarboplatin Versus PaclitaxelCancer TreatmentOncologyGynecology OncologyOvarian Cancer